HEPA
Hepion Pharmaceuticals, Inc.
Set alert
0.18 USD +0.03 +21.79%
0.159 Day range 0.1999
0.035 52-week range 0.18
- YTD
- +200.00%
- 1 year
- +172.73%
- Open
- 0.19
- Prev close
- 0.1478
- Mkt cap
- 22.18M
- Vol
- 31.22K
- Avg vol
- 35.63K
- EPS
- -0.19
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.159
- High
- 0.1999
- Forward P/E
- -0.04
- Beta
- 1.81
- Short ratio
- 0.92
- Inst. own
- 7.85%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2023
- 50-d avg
- 0.64064
- 200-d avg
- 1.07
- 1y target
- 0.00
Financial health
Altman Z-Score
-182.30 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 4
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
Valuation
P/E -0.1×
FY 2016 5y median -0.3× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.2×
FY 2016 5y median 0.5× FY 2025
P/FCF -0.2×
FY 2016 5y median -0.3× FY 2025
EV/EBITDA 0.3×
FY 2016 5y median 0.3× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -579.5%
FY 2016 5y median -317.9% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -310.3%
FY 2016 5y median -84.6% FY 2025
ROIC -147.4%
FY 2016 5y median -147.4% FY 2025
ROA -269.6%
FY 2016 5y median -269.6% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income 78.5%
FY 2016 FY 2025
EPS (diluted) 99.2%
FY 2016 FY 2025
Free Cash Flow 82.0%
FY 2016 FY 2025
Financial Health
Current Ratio 10.3×
FY 2016 5y median 7.2× FY 2025
Quick Ratio 10.3×
FY 2016 5y median 7.2× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2016 5y median 0.5× FY 2025
Interest Coverage -171×
FY 2016 5y median -3432× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31